Cannara Biotech Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2018 2019 2020 2021 2022 2023
Przychód (mln) 0 2 3 17 36 57
Przychód Δ r/r 0.0% 384.7% 21.6% 567.2% 110.6% 59.8%
Marża brutto 36.8% 80.7% 48.0% 60.5% 48.4% 47.6%
EBIT (mln) -2 -10 -12 0 4 12
EBIT Δ r/r 0.0% 462.6% 16.7% -101.6% 1806.6% 223.7%
EBIT (%) -420.0% -487.5% -467.7% 1.1% 10.2% 20.8%
Koszty finansowe (mln) 0 2 1 2 2 4
EBITDA (mln) -2 -9 -9 3 8 16
EBITDA(%) -389.1% -428.8% -357.5% 18.9% 21.2% 27.6%
Podatek (mln) 0 1 1 2 -1 4
Zysk Netto (mln) -2 -14 -14 -3 2 7
Zysk netto Δ r/r 0.0% 474.1% -0.1% -77.6% -174.5% 201.3%
Zysk netto (%) -556.7% -659.4% -541.3% -18.2% 6.4% 12.1%
EPS -0.0347 -0.2 -0.19 -0.0404 0.0263 0.0778
EPS (rozwodnione) -0.0347 -0.2 -0.19 -0.0404 0.0262 0.0778
Ilośc akcji (mln) 69 71 71 77 88 89
Ważona ilośc akcji (mln) 69 71 71 77 88 89
Waluta CAD CAD CAD CAD CAD CAD